Dedicated to improving the lives of people impacted by diabetes through research, education, and clinical care.
Sansum Diabetes Research Institute (SDRI) in Santa Barbara, California, is a global leader in diabetes research. SDRI has been on the cutting edge of diabetes research, education, and clinical care since our founding in 1944 by Dr. William Sansum, the first U.S. physician to manufacture and administer insulin in the treatment of diabetes.
With an established world class reputation for innovation in the field of type 1 diabetes including the artificial pancreas system and diabetes in pregnancy, SDRI is broadening its area of expertise to address a range of issues in type 2 diabetes in an effort to address this growing epidemic.
Sansum Diabetes Research Institute is excited and honored to welcome Dr. Samuel Klein as our new Chief Scientific Officer.Learn about SDRI's COVID-19 vaccination efforts, groundbreaking research studies, a clinical research trial participant's experience at SDRI, and...
SDRI Earns Coveted 4-Star Rating from Charity Navigator and GuideStar’s Highest Seal of Transparency
Sansum Diabetes Research Institute Earns Coveted 4-Star Rating from Charity Navigator and GuideStar’s Highest Seal of Transparency Sansum Diabetes Research Institute (SDRI) is pleased to announce that their strong financial health and commitment to accountability and...
Learn more about what Sansum Diabetes Research Institute has been up to this month! July 2021 Highlights: SDRI's Research at the ADA 81st Scientific Sessions SDRI had 10 presentations/abstracts accepted to the Scientific Sessions this year. Click on the links below to...